The role of inflammation in personalised treatment of omega-3 fatty acids in depression
Abstract
The increasing global burden calls for the development of novel approaches to tackle unmet needs in prevention and treatment of depression underlying biological, psychological and social dysregulations. Depressed patients with chronic low-grade inflammation might be classified as a subgroup of major depressive disorder (MDD); therefore, looking for antidepressant therapies from anti-inflammatory pathways could improve treatment effectiveness for this subgroup of patients. Omega-3 (or n-3) polyunsaturated fatty acids (PUFAs) are anti-inflammatory both in peripheral organs and central nervous systems and have clinically applied in the treatment and prevention of depression, cardiovascular diseases, dyslipidaemia, diabetes and arthritis. Anthropological studies suggest that human beings evolved to a modern diet with less than one-tenth of omega-3 to omega-6 PUFAs intake ratio, which leads to a constitutional bias toward chronic systemic inflammatory status to explain dramatically increasing of depression and chronic medical illnesses in modern world. The presentation is to provide our recent clinical and pre-clinical studies and an overview about the role of inflammation in “mind-body” comorbidity and present anti-inflammatory mechanisms by which n-3 PUFAs may orchestrate the molecular and cellular functions and facilitate the therapeutic pathways in chronic medical illnesses and depression.
Read the paper
Related studies
- Promising Sources of Plant-Derived Polyunsaturated Fatty Acids: A Narrative Review
- Effects of omega-3 polyunsaturated fatty acid intake in patients with chronic kidney disease: Systematic review and meta-analysis of randomized controlled trials
- Effect of omega-3 fatty acids on cognition: an updated systematic review of randomized clinical trials
- The role of omega-3 polyunsaturated fatty acid supplementation in the management of type 2 diabetes mellitus: A narrative review
- Paucity of evidence for a relationship between long-chain omega-3 fatty acid intake and chronic obstructive pulmonary disease: a systematic review
- Omega-3 fatty acid nanocarriers: Characterization and potential applications
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.